Dun & Bradstreet, a global provider of business information and research, has been recognised as a category leader for Know Your Customer Data Solutions by Chartis Research for the third ...

Ratings for Amgen AMGN were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ...

Dun & Bradstreet is a business credit rating agency that assigns ratings to businesses in order to signal the creditworthiness and financial well-being of those businesses to future creditors ...

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen ...

In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...

Emma Raducanu will take on 14th seed Karolina Muchova in the second round of the Dubai Tennis Championships on February 18. Raducanu entered the WTA 1000 event after a disappointing opening-round ...

(RTTNews) - Amgen (AMGN) and Kyowa Kirin Co., Ltd. announced new results from the ongoing ROCKET Phase 3 clinical trial program evaluating rocatinlimab, an investigational T-cell rebalancing ...

Amgen will now move ahead with a phase 2 programme for AMG 133, as it tries to enter a weight-loss category that has been transformed by the approval of Novo Nordisk’s once-weekly GLP-1 agonist ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best retirement stocks to buy according to hedge funds. After much suspense, the US Federal ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...